Summary

The global market for Animal Model Services was estimated to be worth US$ 3627 million in 2024 and is forecast to a readjusted size of US$ 5773 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

The animal model services market is in a structural growth phase driven by multiple converging long-term trends. Pharmaceutical and biotech companies increasingly rely on customized, highly predictive in-vivo models to shorten development timelines and improve candidate translation; concurrently, maturation of gene-editing, humanized models and complex comorbidity models enables providers to deliver more clinically relevant solutions and capture premium service value. Moreover, heightened regulatory scrutiny and safety evaluation requirements for advanced therapeutics (e.g., cell and gene therapies) place animal model services at the core of preclinical compliance and risk management, generating durable demand for established vendors and end-to-end CROs.
Beneath the opportunities lie systemic risks: intensifying ethical and animal-welfare regulations and greater public scrutiny increase approval complexity and compliance costs; the live animal supply chain’s sensitivity around strain purity, SPF status and biosafety means any supply disruption or quality event can cause major experimental delays and reputational harm; additionally, alternative technologies (organoids, organ-on-a-chip, advanced in-vitro systems) are maturing in certain use cases and alter demand boundaries for lower-complexity applications. For companies, investments in compliance, risk mitigation and sustainable operations are now central determinants of long-term competitiveness.

Downstream demand is evolving toward both higher-complexity needs and increased outsourcing. Large pharmaceutical firms and fast-growing biotech companies prefer to outsource complex models to CROs with platform capabilities and quality assurances to reduce fixed costs and improve reproducibility, while academic groups and early-stage teams demand standardized, reproducible models and comparable datasets—creating opportunities for model standardization services and biorepository partnerships. Regionally, rising R&D investment in emerging markets drives rapid local demand for high-quality animal model services, favoring providers that can deliver locally while meeting international compliance standards.

This report aims to provide a comprehensive presentation of the global market for Animal Model Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Animal Model Services by region & country, by Type, and by Application.
The Animal Model Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Model Services.

Market Segmentation
By Company
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
JANVIER LABS
Segment by Type
Rats
Mice
Others
Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Animal Model Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Animal Model Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Animal Model Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Animal Model Services Product Introduction
1.2 Global Animal Model Services Market Size Forecast (2020-2031)
1.3 Animal Model Services Market Trends & Drivers
1.3.1 Animal Model Services Industry Trends
1.3.2 Animal Model Services Market Drivers & Opportunity
1.3.3 Animal Model Services Market Challenges
1.3.4 Animal Model Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal Model Services Players Revenue Ranking (2024)
2.2 Global Animal Model Services Revenue by Company (2020-2025)
2.3 Key Companies Animal Model Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Animal Model Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Animal Model Services
2.6 Animal Model Services Market Competitive Analysis
2.6.1 Animal Model Services Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Animal Model Services Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Model Services as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rats
3.1.2 Mice
3.1.3 Others
3.2 Global Animal Model Services Sales Value by Type
3.2.1 Global Animal Model Services Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Animal Model Services Sales Value, by Type (2020-2031)
3.2.3 Global Animal Model Services Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic & Research Institutes
4.1.2 Pharmaceutical & Biotechnology Companies
4.2 Global Animal Model Services Sales Value by Application
4.2.1 Global Animal Model Services Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Animal Model Services Sales Value, by Application (2020-2031)
4.2.3 Global Animal Model Services Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Animal Model Services Sales Value by Region
5.1.1 Global Animal Model Services Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Animal Model Services Sales Value by Region (2020-2025)
5.1.3 Global Animal Model Services Sales Value by Region (2026-2031)
5.1.4 Global Animal Model Services Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Animal Model Services Sales Value, 2020-2031
5.2.2 North America Animal Model Services Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Animal Model Services Sales Value, 2020-2031
5.3.2 Europe Animal Model Services Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Animal Model Services Sales Value, 2020-2031
5.4.2 Asia Pacific Animal Model Services Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Animal Model Services Sales Value, 2020-2031
5.5.2 South America Animal Model Services Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Animal Model Services Sales Value, 2020-2031
5.6.2 Middle East & Africa Animal Model Services Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal Model Services Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Animal Model Services Sales Value, 2020-2031
6.3 United States
6.3.1 United States Animal Model Services Sales Value, 2020-2031
6.3.2 United States Animal Model Services Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Animal Model Services Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Animal Model Services Sales Value, 2020-2031
6.4.2 Europe Animal Model Services Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Animal Model Services Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Animal Model Services Sales Value, 2020-2031
6.5.2 China Animal Model Services Sales Value by Type (%), 2024 VS 2031
6.5.3 China Animal Model Services Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Animal Model Services Sales Value, 2020-2031
6.6.2 Japan Animal Model Services Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Animal Model Services Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Animal Model Services Sales Value, 2020-2031
6.7.2 South Korea Animal Model Services Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Animal Model Services Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Animal Model Services Sales Value, 2020-2031
6.8.2 Southeast Asia Animal Model Services Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Animal Model Services Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Animal Model Services Sales Value, 2020-2031
6.9.2 India Animal Model Services Sales Value by Type (%), 2024 VS 2031
6.9.3 India Animal Model Services Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Profile
7.1.2 Charles River Laboratories Main Business
7.1.3 Charles River Laboratories Animal Model Services Products, Services and Solutions
7.1.4 Charles River Laboratories Animal Model Services Revenue (US$ Million) & (2020-2025)
7.1.5 Charles River Laboratories Recent Developments
7.2 Envigo
7.2.1 Envigo Profile
7.2.2 Envigo Main Business
7.2.3 Envigo Animal Model Services Products, Services and Solutions
7.2.4 Envigo Animal Model Services Revenue (US$ Million) & (2020-2025)
7.2.5 Envigo Recent Developments
7.3 Taconic Biosciences
7.3.1 Taconic Biosciences Profile
7.3.2 Taconic Biosciences Main Business
7.3.3 Taconic Biosciences Animal Model Services Products, Services and Solutions
7.3.4 Taconic Biosciences Animal Model Services Revenue (US$ Million) & (2020-2025)
7.3.5 Taconic Biosciences Recent Developments
7.4 Jackson Laboratory
7.4.1 Jackson Laboratory Profile
7.4.2 Jackson Laboratory Main Business
7.4.3 Jackson Laboratory Animal Model Services Products, Services and Solutions
7.4.4 Jackson Laboratory Animal Model Services Revenue (US$ Million) & (2020-2025)
7.4.5 Jackson Laboratory Recent Developments
7.5 Crown Biosciences
7.5.1 Crown Biosciences Profile
7.5.2 Crown Biosciences Main Business
7.5.3 Crown Biosciences Animal Model Services Products, Services and Solutions
7.5.4 Crown Biosciences Animal Model Services Revenue (US$ Million) & (2020-2025)
7.5.5 Crown Biosciences Recent Developments
7.6 Shanghai SLAC
7.6.1 Shanghai SLAC Profile
7.6.2 Shanghai SLAC Main Business
7.6.3 Shanghai SLAC Animal Model Services Products, Services and Solutions
7.6.4 Shanghai SLAC Animal Model Services Revenue (US$ Million) & (2020-2025)
7.6.5 Shanghai SLAC Recent Developments
7.7 Shangghai Modelorg
7.7.1 Shangghai Modelorg Profile
7.7.2 Shangghai Modelorg Main Business
7.7.3 Shangghai Modelorg Animal Model Services Products, Services and Solutions
7.7.4 Shangghai Modelorg Animal Model Services Revenue (US$ Million) & (2020-2025)
7.7.5 Shangghai Modelorg Recent Developments
7.8 GenOway
7.8.1 GenOway Profile
7.8.2 GenOway Main Business
7.8.3 GenOway Animal Model Services Products, Services and Solutions
7.8.4 GenOway Animal Model Services Revenue (US$ Million) & (2020-2025)
7.8.5 GenOway Recent Developments
7.9 Syngene International
7.9.1 Syngene International Profile
7.9.2 Syngene International Main Business
7.9.3 Syngene International Animal Model Services Products, Services and Solutions
7.9.4 Syngene International Animal Model Services Revenue (US$ Million) & (2020-2025)
7.9.5 Syngene International Recent Developments
7.10 Psychogenics
7.10.1 Psychogenics Profile
7.10.2 Psychogenics Main Business
7.10.3 Psychogenics Animal Model Services Products, Services and Solutions
7.10.4 Psychogenics Animal Model Services Revenue (US$ Million) & (2020-2025)
7.10.5 Psychogenics Recent Developments
7.11 Pharmaron
7.11.1 Pharmaron Profile
7.11.2 Pharmaron Main Business
7.11.3 Pharmaron Animal Model Services Products, Services and Solutions
7.11.4 Pharmaron Animal Model Services Revenue (US$ Million) & (2020-2025)
7.11.5 Pharmaron Recent Developments
7.12 Pharmalegacy
7.12.1 Pharmalegacy Profile
7.12.2 Pharmalegacy Main Business
7.12.3 Pharmalegacy Animal Model Services Products, Services and Solutions
7.12.4 Pharmalegacy Animal Model Services Revenue (US$ Million) & (2020-2025)
7.12.5 Pharmalegacy Recent Developments
7.13 Vitalstar Biotechnology
7.13.1 Vitalstar Biotechnology Profile
7.13.2 Vitalstar Biotechnology Main Business
7.13.3 Vitalstar Biotechnology Animal Model Services Products, Services and Solutions
7.13.4 Vitalstar Biotechnology Animal Model Services Revenue (US$ Million) & (2020-2025)
7.13.5 Vitalstar Biotechnology Recent Developments
7.14 JANVIER LABS
7.14.1 JANVIER LABS Profile
7.14.2 JANVIER LABS Main Business
7.14.3 JANVIER LABS Animal Model Services Products, Services and Solutions
7.14.4 JANVIER LABS Animal Model Services Revenue (US$ Million) & (2020-2025)
7.14.5 JANVIER LABS Recent Developments
8 Industry Chain Analysis
8.1 Animal Model Services Industrial Chain
8.2 Animal Model Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal Model Services Sales Model
8.5.2 Sales Channel
8.5.3 Animal Model Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer